Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

BACKGROUND: The reciprocal fate decision of mesenchymal stem cells (MSCs) to either bone or adipocytes is determined by Wnt-related signaling and the glucagon-like peptide-1 receptor (GLP-1R). Azoramide, an ER stress alleviator, was reported to have an antidiabetic effect. In this study, we investig...

Full description

Saved in:

Bibliographic Details
Published in:	Stem Cell Res Ther
Main Authors:	Ruan, Banjun, Zhu, Zheng, Yan, Zhao, Yang, Wei, Zhai, Dongsheng, Wang, Li, Ye, Zichen, Lu, Huanyu, Xiang, An, Liang, Jingwei, Jiang, Yinghao, Xu, Chengming, Wang, Zhenyu, Wei, Ming, Lei, Xiaoying, Cao, Xiaorui, Lu, Zifan
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2018
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5845182/ https://ncbi.nlm.nih.gov/pubmed/29523188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0771-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Similar Items